The 10th Microbiome Interactions in Health and Disease meeting will once again bring together leading scientists and clinicians from the fields of microbiology, gastroenterology, neuroscience and public health to discuss the latest developments in this fast-moving area.
Recent studies have revealed the complexity of the gut microbial ecology and its network connectivity to the metabolic regulation of important pathways in the host. Studies on microbiota from various body sites are helping us to understand how microorganisms affect the host. Alterations in microbiome composition have been associated with many non-infectious diseases including inflammatory bowel conditions, autoimmune diseases, cancers and diabetes, although in many cases causality has yet to be established.
This meeting will update current knowledge of how various microbiomes (skin, oral, gut, lung, non-bacterial etc.) communicate with the host and the factors that influence these interactions. The programme will discuss the new developments enabled by metagenomics, metabonomics and other technologies.
This year’s meeting will focus on immune–microbiome interactions and the impact of drugs on the microbiome. We will also discuss interactions between the gut and nervous system and explore the biological understanding emerging from large-scale microbiome studies. Finally, the influence of microbiome on pathogens and infectious disease will be featured.
More information, here